Keyword: Hologic

Upselling customers on high-tech breast cancer screenings is just one way the 3D mammography industry aggressively promotes its product.

The FDA cleared a handful of diagnostics aimed at STIs, including the first to detect chlamydia and gonorrhea outside the genitals.

Hologic launched management software for its mammography machines that can predict the failure of X-ray hardware and help schedule early replacements.

Hologic is acquiring Focal Therapeutics for $125 million in cash to supplement its breast-conserving surgery franchise.

CAR-T maker Cell Medica names Kite’s European chief as CEO; Oncorus poaches a Moderna cancer executive; and Achaogen axes R&D and its C-suite.

Hologic’s stock stumbled despite higher-than-expected earnings, following the departure of its CFO and an FDA letter to its aesthetics arm, Cynosure.

Hologic now expects full-year sales at the unit to be “down materially” on the $390 million it posted in the four quarters starting October 2016.

Here's Friday's medtech news of note.

Diagnostics player Hologic is diving into medical aesthetics with an acquisition of Cynosure worth approximately $1.65 billion.